:: BioReliance ::


		Introduction Genetic Mammalian Traditional Toxicology Studies Gene Therapy Toxicology Studies Transgenic Carcinogenicity Studies Specialty Toxicology Studies Contract Pathology Services Custom Vaccine Toxicology Studies

Darryl L. Goss joins Bioreliance Darryl L. Goss has been appointed Vice President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly formed Business Unit.
Click here to read the press release.

The use of animal models to determine the toxicity of a pharmaceutical, biopharmaceutical or medical device is a required part of evaluating the overall safety of the product and predicting its effects on humans.

Contract Pathology Services

Back to Mammalian Toxicology

BioReliance provides a variety of contract pathology services. For toxicology studies performed in a client’s facility, BioReliance can provide on-site supervision of necropsies. This service includes supervision of the gross necropsy, tissue collection, slide preparation, clinical chemistry and hematology. BioReliance also offers pathology slide reading for both the primary evaluation and peer review from studies performed by clients outside of our laboratories. BioReliance offers unique expertise in many areas including the toxicology and pathology of transgenic animals, gene therapy vectors, pharmaceuticals, biopharmaceuticals, medical devices and hematopathology. We have particular expertise in design, conduct and evaluation of studies in support of programs with special hematological bone marrow needs.

Assays offered by BioReliance:

Assay Description	Protocol
Necropsy and Histopathology Services	PA-100
Pathology Slide Reading	PA-200
Peer Review Pathology Slide Reading	PA-300
Clinical Pathology Services	PA-400

for further information and enquiries please contact: info@bioreliance.com